The drug is produced as a tablet containing 2 mg of dosage leuratadine and is produced in two fourteen numeric blends with a brochure in a printed box with a syrup containing 1.5 mg of dosage dosage per 2 ml and in the form of a 2 ml bottle with a cup and a brochure in the print box.